In this study, therefore, we compared the survival rates between patients who underwent BCT and patients who underwent mastectomy with or without radiotherapy from a relatively large number of BRCA1/2 variant carriers and noncarriers who were drawn from a large series of unselected patients with breast cancer. The gene discussed is BRCA1; the disease is breast carcinoma.